Wire · regulatory
FTC, states accuse Shkreli of flouting lifetime pharma ban with livestreamed trades
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 13 October 2026 · Fusion42 review
Martin Shkreli is accused by the FTC and several states of violating a lifetime ban on pharmaceutical industry involvement by livestreaming and discussing drug-related stock trades, prompting new legal actions.
This Wire brief sits within Fusion42's coverage of Pharma Bro is linked to pharmaceutical industry which aligns with Healthtech Infrastructure but given the sector list, no exact match; closest is Digital Health or Healthtech Infrastructure but none specifically say Pharma, safest to choose null, and 8 sources have reported it between 13 Oct 2026 and 14 Oct 2026.
◆ ◆ The Wire takeaway
You cannot ignore compliance deadlines set by regulators if your product or service ties to pharma. Legal actions against Shkreli show the government is monitoring social media for rule breaches and will act swiftly.
◆ Coverage
8 sources · first reported 13 Oct 2026 · latest 14 Oct 2026
◆ Topics